Two Pioneering Drug Management Companies Partner To Research The Impact Of Genetic Testing On Managing Mental Illness

SinfoníaRx and AltheaDx announced today an agreement to integrate AltheaDx’s IDgenetix® proprietary genetic testing into SinfoníaRx’s medication therapy management (MTM) programs. MTM is a personalized service delivered by pharmacists designed to optimize health outcomes through improved medication treatment. Through the use of the AltheaDx’s IDgenetix® genetic testing, the service will provide an unprecedented level of drug therapy optimization and customization for individual patients.

SinfoníaRx Partners With AltheaDx.pdf